Clinical Trials Browser

Phase 3 × Non-small Cell Lung Cancer Metastatic × aumolertinib × Clear all

NCT05800223 2023-04-05

Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer

Phase 3 Recruiting

Non-small Cell Lung Cancer Metastatic